PB:NYSEProsperity Bancshares, Inc. Analysis
Data as of 2026-07-19 - not real-time
$73.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Prosperity Bancshares is trading at roughly $73.5, comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating a sustained bullish trend. The RSI of 57 and a bullish MACD histogram reinforce this momentum while the price sits near a solid support level around $69.8 and below a near‑term resistance of $75. Valuation metrics suggest the stock is undervalued – a trailing P/E of 13.3 is well below the industry average of 17.8 and the DCF‑derived fair value of $87.6 implies about 8% upside. Fundamentally, the bank delivers strong profitability with an operating margin above 55% and a profit margin of 40%, and revenue growth close to 20% year‑over‑year. The dividend yield of 3.2% and a payout ratio under 45% point to a sustainable income stream, while low beta (≈0.5) and moderate 30‑day volatility (≈21%) keep price swings in check. Recent corporate announcements confirm the completion of a strategic initiative in early July, providing additional confidence in the company’s execution capability. Overall, the combination of technical strength, attractive valuation, solid earnings growth and a reliable dividend makes PB a compelling candidate for investors seeking a blend of growth and income.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key moving averages
- Attractive dividend yield and sustainable payout
- Undervalued relative to peers offering near‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- DCF fair value indicating upside potential
- Low beta and moderate volatility supporting price stability
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Consistent dividend payments with sustainable coverage
- Stable regional market position and low geographic concentration risk
- Solid balance sheet with ample cash relative to debt
Key Metrics & Analysis
Financial Health
Revenue Growth19.90%
Profit Margin40.35%
P/E Ratio13.3
ROE6.73%
ROA1.28%
P/B Ratio0.9
Op. Cash Flow$556.5M
Industry P/E17.8
Technical Analysis
TrendBullish
RSI57.1
Support$69.79
Resistance$75.00
MA 20$72.46
MA 50$70.50
MA 200$69.20
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value$87.57
Target Price$79.62
Upside/Downside8.33%
GradeUndervalued
TypeBlend
Dividend Yield3.24%
Risk Assessment
Beta0.50
Volatility21.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.